We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech for less than cash value

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bmaz001 who wrote (627)1/6/2023 4:53:17 PM
From: Area511 Recommendation

Recommended By

  Read Replies (2) of 683
That was a nice list you did last year (although I suspect most people buying from it in January 22 didn't profit much). Are you going to update it this year?

One that I follow is PASG that has been mentioned in this thread before. As of Q3 2022 they had 213 million cash and marketable securities; 46 million in total liabilities; 54 million shares. So (cash - total liabilities) / shares = about 3.30 and now trading 1.88 after closing 2022 at 1.38. (PASG was on your list last year but last January was trading over $6). Do people see better values than that? Always good to diversify because a decent percentage of these will likely run out of cash before they ever generate significant revenue.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext